We are live on ! Find out more
Steven Cohen

Steven Cohen Point72 Asset Management

AUM $90B Turnover 35.95%
1-Year Est. Return 47.32%
 

Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.

This Fund
S&P 500
This Quarter Est. Return
-0.87%
1 Year Est. Return
+47.32%
3 Year Est. Return
+196.68%
5 Year Est. Return
+253.31%
10 Year Est. Return
+901.75%
AUM
$90B
AUM Growth
-$633M
Cap. Flow
-$1.03B
Cap. Flow %
-1.15%
Top 10 Hldgs %
9.57%
Holding
4,740
New
820
Increased
1,398
Reduced
1,421
Closed
884
Avg Time Held Equity + Options
0.8 years
Top 10 Avg Time Held Equity + Options
1.5 years
Top 20 Avg Time Held Equity + Options
1 year
Avg Time Held Equity only
0.6 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.4 years

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$936M
2
CLS icon
Celestica
CLS
+$624M
3
INTC icon
Intel
INTC
+$414M
4
BA icon
Boeing
BA
+$390M
5
T icon
AT&T
T
+$357M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$677M
2
ASML icon
ASML
ASML
+$524M
3
ORCL icon
Oracle
ORCL
+$445M
4
TSM icon
TSMC
TSM
+$444M
5
SNOW icon
Snowflake
SNOW
+$365M

Sector Composition

Rank Sector Weight
1 Miscellaneous 33.57%
2 Technology 18.01%
3 Industrials 8.74%
4 Consumer Discretionary 8.72%
5 Healthcare 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RY icon
2301
PUT
Royal Bank of Canada
RY
$272B
$2.2M ﹤0.01%
11,200
-8,000
-42% -$1.66M
2025 Q2
5 quarters
ADT icon
2302
ADT
ADT
$7.22B
$2.19M ﹤0.01%
360,692
-325,926
-47% -$2.31M
2026 Q2
1 quarter
FOR icon
2303
Forestar Group
FOR
$1.12B
$2.19M ﹤0.01%
85,051
+21,871
+35% +$622K
2024 Q3
8 quarters
GTLB icon
2304
PUT
GitLab
GTLB
$7.43B
$2.18M ﹤0.01%
46,100
– –
2026 Q1
2 quarters
STNE icon
2305
CALL
StoneCo
STNE
$1.67B
$2.18M ﹤0.01%
233,100
-121,400
-34% -$1.25M
2025 Q4
3 quarters
OCUL icon
2306
Ocular Therapeutix
OCUL
$1.32B
$2.17M ﹤0.01%
283,555
-3,008,638
-91% -$29.4M
2024 Q2
9 quarters
DECK icon
2307
CALL
Deckers Outdoor
DECK
$10.9B
$2.17M ﹤0.01%
27,800
-51,400
-65% -$4.74M
2025 Q4
3 quarters
VISN icon
2308
Vistance Networks
VISN
$800M
$2.17M ﹤0.01%
+363,000
New +$3.57M
2026 Q3
0 quarters
PATH icon
2309
PUT
UiPath
PATH
$6.46B
$2.17M ﹤0.01%
169,000
+146,200
+641% +$2.03M
2025 Q4
3 quarters
SHW icon
2310
PUT
Sherwin-Williams
SHW
$83B
$2.17M ﹤0.01%
6,700
-1,500
-18% -$507K
2024 Q3
8 quarters
ENVX icon
2311
Enovix
ENVX
$291M
$2.16M ﹤0.01%
932,985
+738,622
+380% +$2.32M
2026 Q1
2 quarters
COWZ icon
2312
Pacer US Cash Cows 100 ETF
COWZ
$19.2B
$2.16M ﹤0.01%
+32,414
New +$2.21M
2026 Q3
0 quarters
SD icon
2313
SandRidge Energy
SD
$466M
$2.16M ﹤0.01%
160,293
+36,453
+29% +$508K
2025 Q4
3 quarters
CRNT icon
2314
Ceragon Networks
CRNT
$210M
$2.16M ﹤0.01%
1,044,442
+230,513
+28% +$499K
2026 Q1
2 quarters
SPRB icon
2315
Spruce Biosciences
SPRB
$116M
$2.15M ﹤0.01%
44,258
+15,980
+57% +$810K
2026 Q2
1 quarter
RIO icon
2316
PUT
Rio Tinto
RIO
$129B
$2.15M ﹤0.01%
+22,800
New +$2.21M
2026 Q3
0 quarters
RMBS icon
2317
PUT
Rambus
RMBS
$8.43B
$2.14M ﹤0.01%
+20,000
New +$1.93M
2026 Q3
0 quarters
SANM icon
2318
CALL
Sanmina
SANM
$8.17B
$2.13M ﹤0.01%
9,900
+1,500
+18% +$306K
2025 Q4
3 quarters
CORT icon
2319
PUT
Corcept Therapeutics
CORT
$7.57B
$2.12M ﹤0.01%
18,400
+12,400
+207% +$1.33M
2026 Q2
1 quarter
CLDX icon
2320
Celldex Therapeutics
CLDX
$2.2B
$2.12M ﹤0.01%
65,405
-51,812
-44% -$1.98M
2022 Q3
16 quarters
BOH icon
2321
Bank of Hawaii
BOH
$2.67B
$2.12M ﹤0.01%
+30,747
New +$2.41M
2026 Q3
0 quarters
FIG icon
2322
CALL
Figma
FIG
$9.7B
$2.12M ﹤0.01%
100,800
-200
-0.2% -$4.78K
2026 Q1
2 quarters
JETS icon
2323
PUT
US Global Jets ETF
JETS
$872M
$2.12M ﹤0.01%
75,000
-45,000
-38% -$1.36M
2025 Q3
4 quarters
BH icon
2324
Biglari Holdings Class B
BH
$1.22B
$2.12M ﹤0.01%
6,154
+1,965
+47% +$746K
2025 Q3
4 quarters
NVAX icon
2325
PUT
Novavax
NVAX
$1.31B
$2.11M ﹤0.01%
+195,000
New +$1.75M
2026 Q3
0 quarters

Similar funds

Steven Cohen's Q3 2026 Portfolio in Review

As of Q3 2026, Steven Cohen held 4,740 positions worth $90B, down 0.7% from $90.7B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Steven Cohen's Q3 2026 filing shows 820 new, 1,398 increased, 1,421 reduced and 884 closed positions. Its largest new stake was Celestica: 1,886,416 shares worth $682M. The largest sale was Advanced Micro Devices, an estimated $677M.

By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 32% a quarter earlier, followed by Technology and Industrials.

  • Steven Cohen's largest Q3 2026 buy was Celestica: 1,886,416 shares worth $682M.
  • Steven Cohen added most to Microsoft in Q3 2026, an estimated $936M increase.
  • Steven Cohen's biggest Q3 2026 reduction was Advanced Micro Devices, cutting an estimated $677M.
  • Steven Cohen fully exited Visa in Q3 2026, selling an estimated $297M.
  • Steven Cohen's ten largest holdings make up 9.6% of its $90B portfolio in Q3 2026.
  • Steven Cohen opened 820 new positions and closed 884 in Q3 2026.
  • Steven Cohen's portfolio value fell 0.7% quarter-over-quarter to $90B.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.